"Exploring the Brain's Flexibility: Antidepressants, Ketamine, and Psychedelics"

A study published in Molecular Psychiatry suggests that the antidepressant escitalopram may increase brain plasticity, potentially aiding in the treatment of depression. Other treatments such as ketamine and psychedelics are also being investigated for their effects on brain plasticity. The study used positron emission tomography to measure synaptic vesicle glycoprotein 2A levels in the brain, finding an increase in brain plasticity over three to five weeks of escitalopram treatment. This evidence supports the idea that antidepressant treatment may facilitate brain plasticity, which is crucial for recovering from depression.